Stephanie Chandler Speaks on Trends in the Biotech Industry for Entrepreneurial Success

February 27, 2012 | Attorney News

Jackson Walker partner Stephanie Chandler will be speaking at the closing session of this year’s Emerging Medical Technology Symposium at Innotech on April 4, 2012, in San Antonio, Texas.

The panel, entitled “Pearls for Business Growth and Building Value at Each Stage,” will be moderated by Fred Dinger, the President & CEO of ENTrigue Surgical, Inc. and include panelists Dr. John Harper, Senior Vice President, Global Clinical Development and Clinical Sciences, Kinetic Concepts, Inc.; Lee Cusenbary, General Counsel, Mission Pharmacal Company; and Gary Frashier, President Principal at Management Associates & Chairman of the Board for ViroXis.

Ms. Chandler’s practice emphasizes securities transactions, reporting and compliance; mergers and acquisitions; technology licensing and commercialization, and general corporate work. She assists clients with both the formation of organizations, public and private offering of securities, governance issues and shareholder proxy contests, as well as Securities Act and Exchange Act compliance matters. Her clients include startup companies commercializing innovations in information technology and biotechnology, private investors and private equity and venture capital firms, and large privately held and publicly traded companies. Industries she serves include software, healthcare and life sciences, oil and gas, energy trading, transportation and logistics, educational institutions and construction.